The CMT Research Foundation funds innovative research projects aimed at developing treatments and cures for Charcot-Marie-Tooth disease, supporting both established and emerging investigators.
Funder: CMT Research Foundation
Due Dates (Anticipated): December 2026 | February 2027 | May 2027
Funding Amounts: Typical awards: $100,000–$200,000 per year for 1–3 years; Emerging Researcher: up to $75,000 (Pilot) or $25,000 (Predoctoral).
Summary: Supports innovative research projects to accelerate the development of treatments and cures for Charcot-Marie-Tooth disease (CMT).
Key Information: Letter of Intent (LOI) required prior to full proposal; open to global applicants from academia, nonprofits, and industry.
The CMT Research Foundation funds research projects aimed at developing effective treatments and cures for Charcot-Marie-Tooth disease (CMT), the most common inherited peripheral neuropathy. Grants support both translational and discovery-phase research with a clear path toward clinical application, prioritizing projects that align with the foundation’s mission to deliver impactful solutions for CMT patients. Funding is available for established and emerging investigators, including a dedicated Emerging Researcher Award for early-career scientists and predoctoral students. The foundation welcomes proposals from academic, nonprofit, and for-profit organizations worldwide and encourages collaborative and innovative approaches that address key barriers to CMT drug development.